WALTHAM, Mass.– Revvity, Inc. (NYSE:RVTY) today announced the launch of its new In Vivo Imaging Center of Excellence in Morrisville, North Carolina, located in the state’s Research Triangle. The facility brings together Revvity’s scientific and engineering expertise to accelerate development of next-generation imaging systems powered by AI software tools and advanced technologies.
The center houses R&D teams across software, hardware, applied biology, machine learning, optical, microCT, and ultrasound disciplines. By uniting these teams under one roof, Revvity aims to address key challenges in disease research workflows and create innovative solutions for scientists worldwide.
“The In Vivo Imaging Center of Excellence will allow Revvity to drive innovation at a faster pace and stay at the forefront of not only in vivo imaging, but also other imaging modalities shaping life sciences worldwide,” said Kevin Quick, vice president of platforms, life sciences. “Having these teams under one roof benefits not only our company, but also the researchers and scientists whom we collaborate with – from teams investigating the progression of cancer and disease, tissue morphology, or therapeutic efficacy.”
The site is focused on advancing instruments and software for optical, x-ray CT, ultrasound, and multimodal AI analysis. Current technologies showcased at the facility include Revvity’s IVIS™ optical imaging systems, Quantum™ GX3 microCT system, Vega™ automated preclinical ultrasound system, and VivoJect™ Image-Guided Injection System for targeted delivery of cells and therapies.
